CLEVELAND, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that its Board of Directors has declared a regular quarterly cash dividend of $1.80 per share of common stock to shareholders of record as of September 2, 2025. The dividend is payable September 12, 2025. This is the company's 301st consecutive quarterly dividend. Parker has increased its annual dividends per share paid to shareholders for 69 consecutive ...

Core Points - Xenia Hotels & Resorts, Inc. announced a cash dividend of $0.14 per share for Q2 2025, payable on July 15, 2025, to shareholders of record as of June 30, 2025 [1] - The Board of Directors also authorized a share repurchase program of up to $100 million, with approximately $180 million remaining under total repurchase authorization as of May 13, 2025 [2] - Xenia is a self-advised and self-administered REIT focused on luxury and upper upscale hotels, owning 30 properties with a total of 8,868 rooms across 14 states [3]

Core Points - Bio-Techne Corporation announced a quarterly dividend of $0.08 per share for the quarter ended March 31, 2025, payable on May 30, 2025, to shareholders of record on May 19, 2025 [1] - The company has approved a new share repurchase program authorizing the repurchase of up to $500 million of common stock, starting May 8, 2025, replacing the previous program [2] - Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and employs around 3,100 people globally [3] Dividend Information - The quarterly dividend is set at $0.08 per share for the quarter ended March 31, 2025 [1] - The dividend payment date is May 30, 2025, with a record date of May 19, 2025 [1] Share Repurchase Program - The new share repurchase program allows for the repurchase of up to $500 million of common stock [2] - The program's execution will depend on share price, economic conditions, and regulatory requirements [2] - The company retains the right to suspend, amend, or discontinue the program at any time [2] Company Overview - Bio-Techne is a global life sciences company providing tools and bioactive reagents for research and clinical diagnostics [3] - The company's products support scientific investigations into biological processes and disease progression, aiding drug discovery and clinical testing [3] - Bio-Techne has a diverse portfolio with thousands of products [3]